Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mindray raises FY13 guidance in spite of “mixed bag” Q2

This article was originally published in Clinica

Executive Summary

Mindray Medical, one of China’s largest homegrown medtech companies, has put out what analysts deem to be a patchy performance in the second quarter this year. Nonetheless, this did not stop the firm from raising its outlook for full-year revenue growth, which it now expects to be 18%, up from its previous guidance of 17%.

Topics

UsernamePublicRestriction

Register

MT100713

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel